The MKPs (mitogen-activated protein kinase phosphatases) are a family of at least ten DUSPs (dual-specificity phosphatases) which function to terminate the activity of the MAPKs (mitogen-activated protein kinases). Several members have already been demonstrated to have distinct roles in immune function, cancer, fetal development and metabolic disorders. One DUSP of renewed interest is the inducible nuclear phosphatase MKP-2, which dephosphorylates both ERK (extracellular-signal-regulated kinase) and JNK (c-Jun N-terminal kinase) in vitro. Recently, the understanding of MKP-2 function has been advanced due to the development of mouse knockout models, which has resulted in the discovery of novel roles for MKP-2 in the regulation of sepsis, infection and cell-cycle progression that are distinct from those of other DUSPs. However, many functions for MKP-2 still await to be characterized.
Skip Nav Destination
Article navigation
February 2012
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
Conference Article|
January 19 2012
MKP-2: out of the DUSP-bin and back into the limelight
Ahmed Lawan;
Ahmed Lawan
1Division of Cell Biology, University of Strathclyde, Strathclyde Institute of Pharmacy and Biomedical Sciences, 161 Cathedral Street, Glasgow G4 0RE, U.K.
Search for other works by this author on:
Emma Torrance;
Emma Torrance
1Division of Cell Biology, University of Strathclyde, Strathclyde Institute of Pharmacy and Biomedical Sciences, 161 Cathedral Street, Glasgow G4 0RE, U.K.
Search for other works by this author on:
Sameer Al-Harthi;
Sameer Al-Harthi
1Division of Cell Biology, University of Strathclyde, Strathclyde Institute of Pharmacy and Biomedical Sciences, 161 Cathedral Street, Glasgow G4 0RE, U.K.
Search for other works by this author on:
Muhannad Shweash;
Muhannad Shweash
1Division of Cell Biology, University of Strathclyde, Strathclyde Institute of Pharmacy and Biomedical Sciences, 161 Cathedral Street, Glasgow G4 0RE, U.K.
Search for other works by this author on:
Sulaiman Alnasser;
Sulaiman Alnasser
1Division of Cell Biology, University of Strathclyde, Strathclyde Institute of Pharmacy and Biomedical Sciences, 161 Cathedral Street, Glasgow G4 0RE, U.K.
Search for other works by this author on:
Thikryat Neamatallah;
Thikryat Neamatallah
1Division of Cell Biology, University of Strathclyde, Strathclyde Institute of Pharmacy and Biomedical Sciences, 161 Cathedral Street, Glasgow G4 0RE, U.K.
Search for other works by this author on:
Juliane Schroeder;
Juliane Schroeder
1Division of Cell Biology, University of Strathclyde, Strathclyde Institute of Pharmacy and Biomedical Sciences, 161 Cathedral Street, Glasgow G4 0RE, U.K.
Search for other works by this author on:
Robin Plevin
Robin Plevin
1
1Division of Cell Biology, University of Strathclyde, Strathclyde Institute of Pharmacy and Biomedical Sciences, 161 Cathedral Street, Glasgow G4 0RE, U.K.
1To whom correspondence should be addressed (email [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
July 14 2011
Online ISSN: 1470-8752
Print ISSN: 0300-5127
© The Authors Journal compilation © 2012 Biochemical Society
2012
Biochem Soc Trans (2012) 40 (1): 235–239.
Article history
Received:
July 14 2011
Citation
Ahmed Lawan, Emma Torrance, Sameer Al-Harthi, Muhannad Shweash, Sulaiman Alnasser, Thikryat Neamatallah, Juliane Schroeder, Robin Plevin; MKP-2: out of the DUSP-bin and back into the limelight. Biochem Soc Trans 1 February 2012; 40 (1): 235–239. doi: https://doi.org/10.1042/BST20110648
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.